ReviewHealth economics review2016
Does performance-based financing increase value for money in low- and middle- income countries? A systematic review.
Review in Health economics review, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Interventions to improve pharmacists' competency in chronic disease management: a systematic review of randomized controlled trials.BMC medical education · 2024Pooled it
- Paying for performance to improve the delivery of health interventions in low- and middle-income countries.The Cochrane database of systematic reviews · 2021Pooled it
- The evidence gap on gendered impacts of performance-based financing among family physicians for chronic disease care: a systematic review reanalysis in contexts of single-payer universal coverage.Human resources for health · 2020Pooled it
- Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019Pooled it
- Decentralized facility financing versus performance-based payments in primary health care: a large-scale randomized controlled trial in Nigeria.BMC medicine · 2021Trial
- Cost-effectiveness of results-based financing, Zambia: a cluster randomized trial.Bulletin of the World Health Organization · 2018Trial
- Challenges and opportunities in financing urban primary healthcare in Iran: pathways to universal health coverage.BMC primary care · 2026Article
- Counter-verification in performance-based financing: key insights from the Côte d'Ivoire experience.Global health action · 2025Article
- Effects of financial compensation structures on community health worker performance, motivation, and retention: evidence from a multi-arm quasi-experiment in Uganda.Frontiers in health services · 2025Article
- Inclusion of disability in primary healthcare facilities and socioeconomic inequity in Brazil.Revista de saude publica · 2024Article
- Cost-effectiveness of implementing performance-based financing for improving maternal and child health in Ethiopia.PloS one · 2024Article
- Evaluation of a results-based financing nutrition intervention for tuberculosis patients in Madhya Pradesh, India, implemented during the COVID-19 pandemic.BMC global and public health · 2023Article
- Comparative effectiveness of financing models in development assistance for health and the role of results-based funding approaches: a scoping review.Globalization and health · 2023Article
- The Flipped Break-Even: Re-Balancing Demand- and Supply-Side Financing of Health Centers in Cambodia.International journal of environmental research and public health · 2023Article
- Article
- Pay for performance in primary care: the contribution of the Programme for Improving Access and Quality of Primary Care (PMAQ) on avoidable hospitalisations in Brazil, 2009-2018.BMJ global health · 2021Article
- A more practical guide to incorporating health equity domains in implementation determinant frameworks.Implementation science communications · 2021Article
- The effects of performance-based financing on neonatal health outcomes in Burundi, Lesotho, Senegal, Zambia and Zimbabwe.Health policy and planning · 2021Article
- Health Insurance in Sub-Saharan Africa: A Scoping Review of the Methods Used to Evaluate its Impact.Applied health economics and health policy · 2020Article
- Pay for Performance: A Reflection on How a Global Perspective Could Enhance Policy and Research.International journal of health policy and management · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Governments of low- and middle-income countries (LMICs) are widely implementing performance-based financing (PBF) to improve healthcare services. However, it is unclear whether PBF provides good value for money compared to status quo or other interventions aimed at strengthening the healthcare system in LMICs. The objective of this systematic review is to identify and synthesize the existing literature that examines whether PBF represents an efficient manner of investing resources. We considered PBF to be efficient when improved care quality or quantity was achieved with equal or lower costs, or alternatively, when the same quality of care was achieved using less financial resources. A manual search of the reference lists of two recent systematic reviews on economic evaluations of PBF was conducted to identify articles that met our inclusion and exclusion criteria. Subsequently, a search strategy was developed with the help of a librarian. The following databases and search engines were used: PubMed, EconLit, Google Scholar and Google. Experts on economic evaluations were consulted for validation of the selected studies. A total of seven articles from five LMICs were selected for this review. We found the overall strength of the evidence to be weak. None of the articles were full economic evaluations; they did not make clear connections between the costs and effects of PBF. Only one study reported using a randomized controlled trial, but issues with the randomization procedure were reported. Important alternative interventions to strengthen the capacities of the healthcare system have not been considered. Few studies examined the costs and consequences of PBF in the long term. Important costs and consequences were omitted from the evaluations. Few LMICs are represented in the literature, despite wide implementation. Lastly, most articles had at least one author employed by an organization involved in the implementation of PBF, thereby resulting in potential conflicts of interest. Stronger empirical evidence on whether PBF represents good value for money in LMICs is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.